AI is finally curing cancer
Summary
AI technology is showing promising advancements in treating cancer, potentially marking a major breakthrough in healthcare.
Similar Articles
There's An AI For That: the first AI cancer drug just worked
AI is transforming both ends of cancer care: Recursion's REC-617 became the first AI-designed drug to shrink tumors in a patient within 12 months, AI-assisted mammography found 30% more cancers in a 100k-person Swedish trial, and AlphaFold uncovered a hidden cell-transport switch (AVL9) that turns out to be an off-switch for cancer metastasis. Yet no AI-designed cancer drug is approved, and the historic 90% clinical trial failure rate remains unbroken.
AI isn’t close to curing cancer. This startup says it knows what it will take.
Biotech startup Vivodyne claims current AI models lack sufficient human tissue data for effective drug discovery and has developed robotic labs called HIVE to generate this data, aiming to improve preclinical testing for diseases like cancer.
When cancer is cured by AI, that's when normal people will realize
作者评论道，普通人对AI近期的快速进步毫不在意，只有当AI真正攻克癌症这类重大疾病时，大众才会意识到AI变革的力量。
Will AI help us cure cancer by 2030?
An opinion piece discussing the potential of AI to cure cancer by 2030, inviting reader engagement.
AI is accelerating drug development
AI is transforming U.S. pharmaceutical R&D by accelerating drug discovery, preclinical testing, clinical trials, and regulatory review, with early evidence suggesting it could cut development times by roughly half and reduce costs.